Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Velocity Clinical Research- Covington, Louisiana

Verified

Basic Information

Site Overview

Source: Human-provided.

Velocity Clinical Research – Covington is a dedicated clinical trial research site located in Covington, Louisiana, United States. The site is part of the global Velocity Clinical Research network, an integrated site organization that partners with pharmaceutical, biotechnology, and medical device companies to conduct clinical trials and support the development of new therapies and healthcare innovations. The Covington facility conducts Phase II–IV clinical studies across multiple therapeutic areas including internal medicine, vaccines, infectious diseases, endocrinology, cardiology, and metabolic disorders. The center works with experienced physician investigators, clinical research coordinators, and trained healthcare professionals to ensure accurate study execution, regulatory compliance, and patient safety throughout the research process. The site is equipped with modern clinical research infrastructure such as patient consultation rooms, laboratory support, investigational…

Source: Trial-derived.
31Total Trials
Source: Trial-derived.
1Recruiting Trials
Source: Trial-derived.
8Active Trials
Source: Trial-derived.
19Completed Trials
Source: Trial-derived.
23Unique Conditions
Source: Trial-derived.
15Unique Sponsors

Affiliations

Conditions

Source: Trial-derived. COVID-19 (4)Source: Trial-derived. Dermatitis Atopic (4)Source: Trial-derived. SARS-CoV-2 (4)Source: Trial-derived. Contraception (2)Source: Trial-derived. Gastro-Intestinal Tolerance (2)Source: Trial-derived. Hypercholesterolemia (2)Source: Trial-derived. Acute Gastroenteritis (1)Source: Trial-derived. Cytomegalovirus Infection (1)

Sponsors

Source: Trial-derived. ModernaTX, Inc. (9)Source: Trial-derived. Abbott Nutrition (4)Source: Trial-derived. Sanofi (4)Source: Trial-derived. Pfizer (3)Source: Trial-derived. Merck Sharp & Dohme LLC (2)Source: Trial-derived. Novavax (2)Source: Trial-derived. Abbott Molecular (1)Source: Trial-derived. Currax Pharmaceuticals (1)

Research Technology

Research technology inferred from trial participation

Source: AI-inferred. Electronic source (eSource) system

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. PCR / molecular
Source: AI-inferred. Clinical microbiology culture
Source: AI-inferred. ELISA / immunoassay
Source: AI-inferred. Timed pharmacokinetic sampling and processing

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Cardiac monitoring
Source: AI-inferred. Electronic participant diary (eDiary) system
Source: AI-inferred. Electronic participant diary (eDiary/ePRO)
Source: AI-inferred. Hemagglutination inhibition (HAI) antibody assay
Source: AI-inferred. Hemagglutination inhibition (HI) serology assay
Source: AI-inferred. Interferon-gamma release assay (IGRA) tuberculosis testing
Source: AI-inferred. Obstetric delivery and newborn assessment facility
Source: AI-inferred. Vaccine immunogenicity serology